Workshop on Future Opportunities for
Combination Biological Therapy of Cancer

Workshop Main Page   |   Presentations Slides & Schedules   |   Published Documents & News Releases
CME Information   |   Faculty

November 1, 2007
Seaport World Trade Center
Boston, Massachusetts

Drawing on dialogue initiated among leaders in the field at a highly successful planning workshop sponsored by the iSBTc in 2006, this in-depth program will provide an assessment of state-of the-art opportunities for combining immune-stimulating agents with other cancer biologics as well as conventional antineoplastic agents. This highly interactive program will provide a venue for intensive scientific dialogue among key stakeholders regarding both strategic opportunities and central obstacles to realizing the potential of combination approaches for the biological therapy of cancer. It is anticipated that participants in this important program will include broad representation by investigators from academia, industry and regulatory agencies in the U.S., Europe and beyond.

Organizers

Bernard A. Fox, PhD
Earle A. Chiles Research Institute		 Thomas F. Gajewski, MD, PhD
University of Chicago
 
Rachel W. Humphrey, MD
Bristol-Myers Squibb Company		 Hyam I. Levitsky, MD
Johns Hopkins University School of Medicine
 
Jon M. Wigginton, MD
Merck & Co., Inc.


Faculty

Michael B. Atkins, MD
Beth Israel Deaconess Medical Center		 Andrew D. Barofsky, JD, MBA
Oregon Biomedical Engineering Institute, Inc.
 
Ashok Batra, MD
Food and Drug Administration		 Bruce R. Blazar, MD
University of Minnesota
 
Lieping Chen, MD, PhD
Johns Hopkins University
School of Medicine		 George Coukos, MD, PhD
University of Pennsylvania Medical Center
 
Glenn Dranoff, MD
Dana-Farber Cancer Institute 		Leisha A. Emens, MD, PhD
Johns Hopkins University
 
James H. Finke, PhD
Cleveland Clinic Foundation		 Bernard A. Fox, PhD
Earle A. Chiles Research Institute
 
Thomas F. Gajewski, MD, PhD
University of Chicago		 Douglas R. Green, PhD
St. Jude Children's Research Hospital
 
Ronald E. Gress, MD
NCI, NIH		 Peter Hersey, MD, PhD
University of Newcastle
 
Rachel W. Humphrey, MD
Bristol-Myers Squibb Company		 Anne Letsch, MD
Charité-Campus Benjamin Franklin
 
Steven K. Libutti, MD
National Cancer Institute		 David F. McDermott, MD
Beth Israel Deaconess Medical Center
 
James W. Mier, MD
Beth Israel Deaconess Medical Center		 Geoffrey M. Nichol, MBChB, MBA
Medarex, Inc.
 
Jon M. Wigginton, MD
Merck & Co., Inc.		 Heinz Zwierzina, MD
Innsbruck Medical University